Loading organizations...
NextSteps Capital provides flexible debt capital and minority equity to lower middle-market businesses. The firm employs a research-driven methodology, utilizing contextualized analysis of innovation trends to pinpoint investment opportunities. They focus on companies at critical growth inflection points, aiming to accelerate development through tailored financial solutions.
Established in 2013, NextSteps Capital was founded on the insight that lower middle-market enterprises often lack suitable capital structures. The firm recognized a market need for partners offering flexible funding and a deep understanding of dynamic market forces. This foundational premise guides their engagement with growth-oriented operators.
NextSteps Capital primarily serves lower middle-market business owners seeking strategic capital for substantial expansion. The firm envisions becoming a pivotal financial ally, empowering these enterprises to leverage market changes and achieve long-term objectives. They aim to unlock potential by aligning investment expertise with the unique needs of scaling companies.
Nextsteps Capital has 3 tracked investments across 1 company. The latest tracked deal is $32.0M Series C in Deciphex in January 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 1, 2025 | Deciphex | $32.0M Series C | — | ACT Venture Capital, Amino Collective, Hummingbird Ventures, MizMaa Ventures, Molten Ventures, NOT Boring Capital, Seroba Life Sciences, Charles River Laboratories, HBAN Medtech Syndicate, Irrus Investments |
| May 1, 2022 | Deciphex | $12.0M Series B | ACT Venture Capital | Molten Ventures, Seroba Life Sciences, Charles River Laboratories, HBAN Medtech Syndicate, Irrus Investments, Novartis |
| May 21, 2019 | Deciphex | $2.3M Other Equity | — | ACT Venture Capital, Enterprise Ireland, GI Partners OF Illinois, Inova Personalized Health Accelerator, Irrus Investments |
